 | • レポートコード：QYR9ST00030 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のアルツハイマー病患者市場について調査・分析し、以下の構成でお届け致します。アルツハイマー病患者の種類別には、エクセロン、アリセプト、ナメンダ、ラザダイン、アクスラ、エビクサ、ヌートロピル、プロメタックス、Memac、エランツに、用途別には、病院、ドラッグストアに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別アルツハイマー病患者売上データ ・地域別アルツハイマー病患者市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別アルツハイマー病患者市場規模：エクセロン、アリセプト、ナメンダ、ラザダイン、アクスラ、エビクサ、ヌートロピル、プロメタックス、Memac、エランツ ・用途別アルツハイマー病患者市場規模：病院、ドラッグストア ・主要メーカーの企業情報：Forest Laboratorie、Eisai、H. Lundbeck A/S、Novartis、Merz GmbH & Co. KGaA、Johnson & Johnson、UCB ・アルツハイマー病患者の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Alzheimer’s is a complex disease，though many marketed drugs have been approved for Alzheimer’s disease, but it still remains a significant area of unmet medical need. Currently there’s no cure for Alzheimer’s and its still waiting for its key product, numerous companies are developing novel treatments.As the risk of getting the disease increases with age, the number of patients with the illness to be found in community will depend on the proportion of older people in the group.
Traditionally, the developed countries have large proportions of elderly people, and so they have many cases of Alzheimer’s disease in the community at one time.
At the mean time, developing countries are also undergoing a demographic transition so that more and more persons are surviving to an old age.
The global Alzheimer’s Disease Patients market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alzheimer’s Disease Patients market based on company, product type, end user and key regions.
This report studies the global market size of Alzheimer’s Disease Patients in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alzheimer’s Disease Patients in these regions.
This research report categorizes the global Alzheimer’s Disease Patients market by top players/brands, region, type and end user. This report also studies the global Alzheimer’s Disease Patients market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Forest Laboratorie
Eisai
H. Lundbeck A/S
Novartis
Merz GmbH & Co. KGaA
Johnson & Johnson
UCB
Market size by Product
Exelon
Aricept
Namenda
Razadyne
Axura
Ebixa
Nootropil
Prometax
Memac
Eranz
Market size by End User
Hospital
Drug Store
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Alzheimer’s Disease Patients market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Alzheimer’s Disease Patients market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Alzheimer’s Disease Patients companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Alzheimer’s Disease Patients submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Alzheimer’s Disease Patients are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alzheimer’s Disease Patients market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Alzheimer’s Disease Patients Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Alzheimer’s Disease Patients Market Size Growth Rate by Product
1.4.2 Exelon
1.4.3 Aricept
1.4.4 Namenda
1.4.5 Razadyne
1.4.6 Axura
1.4.7 Ebixa
1.4.8 Nootropil
1.4.9 Prometax
1.4.10 Memac
1.4.11 Eranz
1.5 Market by End User
1.5.1 Global Alzheimer’s Disease Patients Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Drug Store
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alzheimer’s Disease Patients Market Size
2.1.1 Global Alzheimer’s Disease Patients Revenue 2014-2025
2.1.2 Global Alzheimer’s Disease Patients Sales 2014-2025
2.2 Alzheimer’s Disease Patients Growth Rate by Regions
2.2.1 Global Alzheimer’s Disease Patients Sales by Regions
2.2.2 Global Alzheimer’s Disease Patients Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Alzheimer’s Disease Patients Sales by Manufacturers
3.1.1 Alzheimer’s Disease Patients Sales by Manufacturers
3.1.2 Alzheimer’s Disease Patients Sales Market Share by Manufacturers
3.1.3 Global Alzheimer’s Disease Patients Market Concentration Ratio (CR5 and HHI)
3.2 Alzheimer’s Disease Patients Revenue by Manufacturers
3.2.1 Alzheimer’s Disease Patients Revenue by Manufacturers (2014-2019)
3.2.2 Alzheimer’s Disease Patients Revenue Share by Manufacturers (2014-2019)
3.3 Alzheimer’s Disease Patients Price by Manufacturers
3.4 Alzheimer’s Disease Patients Manufacturing Base Distribution, Product Types
3.4.1 Alzheimer’s Disease Patients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alzheimer’s Disease Patients Product Type
3.4.3 Date of International Manufacturers Enter into Alzheimer’s Disease Patients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Alzheimer’s Disease Patients Sales by Product
4.2 Global Alzheimer’s Disease Patients Revenue by Product
4.3 Alzheimer’s Disease Patients Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Alzheimer’s Disease Patients Breakdown Data by End User
6 North America
6.1 North America Alzheimer’s Disease Patients by Countries
6.1.1 North America Alzheimer’s Disease Patients Sales by Countries
6.1.2 North America Alzheimer’s Disease Patients Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Alzheimer’s Disease Patients by Product
6.3 North America Alzheimer’s Disease Patients by End User
7 Europe
7.1 Europe Alzheimer’s Disease Patients by Countries
7.1.1 Europe Alzheimer’s Disease Patients Sales by Countries
7.1.2 Europe Alzheimer’s Disease Patients Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alzheimer’s Disease Patients by Product
7.3 Europe Alzheimer’s Disease Patients by End User
8 Asia Pacific
8.1 Asia Pacific Alzheimer’s Disease Patients by Countries
8.1.1 Asia Pacific Alzheimer’s Disease Patients Sales by Countries
8.1.2 Asia Pacific Alzheimer’s Disease Patients Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Alzheimer’s Disease Patients by Product
8.3 Asia Pacific Alzheimer’s Disease Patients by End User
9 Central & South America
9.1 Central & South America Alzheimer’s Disease Patients by Countries
9.1.1 Central & South America Alzheimer’s Disease Patients Sales by Countries
9.1.2 Central & South America Alzheimer’s Disease Patients Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Alzheimer’s Disease Patients by Product
9.3 Central & South America Alzheimer’s Disease Patients by End User
10 Middle East and Africa
10.1 Middle East and Africa Alzheimer’s Disease Patients by Countries
10.1.1 Middle East and Africa Alzheimer’s Disease Patients Sales by Countries
10.1.2 Middle East and Africa Alzheimer’s Disease Patients Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Alzheimer’s Disease Patients by Product
10.3 Middle East and Africa Alzheimer’s Disease Patients by End User
11 Company Profiles
11.1 Forest Laboratorie
11.1.1 Forest Laboratorie Company Details
11.1.2 Company Business Overview
11.1.3 Forest Laboratorie Alzheimer’s Disease Patients Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Forest Laboratorie Alzheimer’s Disease Patients Products Offered
11.1.5 Forest Laboratorie Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Company Business Overview
11.2.3 Eisai Alzheimer’s Disease Patients Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Eisai Alzheimer’s Disease Patients Products Offered
11.2.5 Eisai Recent Development
11.3 H. Lundbeck A/S
11.3.1 H. Lundbeck A/S Company Details
11.3.2 Company Business Overview
11.3.3 H. Lundbeck A/S Alzheimer’s Disease Patients Sales, Revenue and Gross Margin (2014-2019)
11.3.4 H. Lundbeck A/S Alzheimer’s Disease Patients Products Offered
11.3.5 H. Lundbeck A/S Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Alzheimer’s Disease Patients Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Alzheimer’s Disease Patients Products Offered
11.4.5 Novartis Recent Development
11.5 Merz GmbH & Co. KGaA
11.5.1 Merz GmbH & Co. KGaA Company Details
11.5.2 Company Business Overview
11.5.3 Merz GmbH & Co. KGaA Alzheimer’s Disease Patients Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Merz GmbH & Co. KGaA Alzheimer’s Disease Patients Products Offered
11.5.5 Merz GmbH & Co. KGaA Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Company Business Overview
11.6.3 Johnson & Johnson Alzheimer’s Disease Patients Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Johnson & Johnson Alzheimer’s Disease Patients Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 UCB
11.7.1 UCB Company Details
11.7.2 Company Business Overview
11.7.3 UCB Alzheimer’s Disease Patients Sales, Revenue and Gross Margin (2014-2019)
11.7.4 UCB Alzheimer’s Disease Patients Products Offered
11.7.5 UCB Recent Development
12 Future Forecast
12.1 Alzheimer’s Disease Patients Market Forecast by Regions
12.1.1 Global Alzheimer’s Disease Patients Sales Forecast by Regions 2019-2025
12.1.2 Global Alzheimer’s Disease Patients Revenue Forecast by Regions 2019-2025
12.2 Alzheimer’s Disease Patients Market Forecast by Product
12.2.1 Global Alzheimer’s Disease Patients Sales Forecast by Product 2019-2025
12.2.2 Global Alzheimer’s Disease Patients Revenue Forecast by Product 2019-2025
12.3 Alzheimer’s Disease Patients Market Forecast by End User
12.4 North America Alzheimer’s Disease Patients Forecast
12.5 Europe Alzheimer’s Disease Patients Forecast
12.6 Asia Pacific Alzheimer’s Disease Patients Forecast
12.7 Central & South America Alzheimer’s Disease Patients Forecast
12.8 Middle East and Africa Alzheimer’s Disease Patients Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alzheimer’s Disease Patients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Alzheimer's Disease Patients Product Picture
Table Alzheimer's Disease Patients Market Segments
Table Key Manufacturers Alzheimer's Disease Patients Covered
Table Global Alzheimer's Disease Patients Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Alzheimer's Disease Patients Sales Market Share by Product 2014-2025
Figure Exelon Product Picture
Table Major Manufacturers of Exelon
Figure Aricept Product Picture
Table Major Manufacturers of Aricept
Figure Namenda Product Picture
Table Major Manufacturers of Namenda
Figure Razadyne Product Picture
Table Major Manufacturers of Razadyne
Figure Axura Product Picture
Table Major Manufacturers of Axura
Figure Ebixa Product Picture
Table Major Manufacturers of Ebixa
Figure Nootropil Product Picture
Table Major Manufacturers of Nootropil
Figure Prometax Product Picture
Table Major Manufacturers of Prometax
Figure Memac Product Picture
Table Major Manufacturers of Memac
Figure Eranz Product Picture
Table Major Manufacturers of Eranz
Table Global Alzheimer's Disease Patients Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Drug Store
Figure Alzheimer's Disease Patients Report Years Considered
Figure Global Alzheimer's Disease Patients Market Size 2014-2025 (Million US$)
Figure Global Alzheimer's Disease Patients Sales 2014-2025 (K Units)
Table Global Alzheimer's Disease Patients Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Alzheimer's Disease Patients Sales by Regions 2014-2019 (K Units)
Table Global Alzheimer's Disease Patients Sales Market Share by Regions 2014-2019
Figure Global Alzheimer's Disease Patients Sales Market Share by Regions 2014-2019
Figure 2018 Global Alzheimer's Disease Patients Sales Market Share by Regions
Table Global Alzheimer's Disease Patients Revenue by Regions 2014-2019 (Million US$)
Table Global Alzheimer's Disease Patients Revenue Market Share by Regions 2014-2019
Figure Global Alzheimer's Disease Patients Revenue Market Share by Regions 2014-2019
Figure 2018 Global Alzheimer's Disease Patients Revenue Market Share by Regions
Table Global Alzheimer's Disease Patients Sales by Manufacturers (2014-2019) (K Units)
Table Global Alzheimer's Disease Patients Sales Share by Manufacturers (2014-2019)
Figure Global Alzheimer's Disease Patients Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Alzheimer's Disease Patients Revenue by Manufacturers (2014-2019) (Million USD)
Table Alzheimer's Disease Patients Revenue Share by Manufacturers (2014-2019)
Figure Alzheimer's Disease Patients Value Share by Manufacturers in 2018
Table Key Manufacturers Alzheimer's Disease Patients Price (2014-2019) (USD/Unit)
Table Alzheimer's Disease Patients Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Alzheimer's Disease Patients Product Type
Table Date of International Manufacturers Enter into Alzheimer's Disease Patients Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Alzheimer's Disease Patients Sales by Product (2014-2019) (K Units)
Table Global Alzheimer's Disease Patients Sales Share by Product (2014-2019)
Figure Global Alzheimer's Disease Patients Sales Market Share by Product (2014-2019)
Figure Global Alzheimer's Disease Patients Sales Market Share by Product in 2018
Table Global Alzheimer's Disease Patients Revenue by Product (2014-2019) (Million US$)
Table Global Alzheimer's Disease Patients Revenue Share by Product (2014-2019)
Figure Global Alzheimer's Disease Patients Revenue Market Share by Product (2014-2019)
Figure Global Alzheimer's Disease Patients Revenue Market Share by Product in 2018
Table Alzheimer's Disease Patients Price by Product 2014-2019 (USD/Unit)
Table Global Alzheimer's Disease Patients Sales by End User (2014-2019) (K Units)
Table Global Alzheimer's Disease Patients Sales Share by End User (2014-2019)
Figure Global Sales Alzheimer's Disease Patients Market Share by End User (2014-2019)
Figure Global Sales Alzheimer's Disease Patients Market Share by End User in 2018
Figure North America Alzheimer's Disease Patients Sales Growth Rate 2014-2019 (K Units)
Figure North America Alzheimer's Disease Patients Revenue Growth Rate 2014-2019 (Million US$)
Table North America Alzheimer's Disease Patients Sales by Countries (2014-2019) (K Units)
Table North America Alzheimer's Disease Patients Sales Market Share by Countries (2014-2019)
Figure 2018 North America Alzheimer's Disease Patients Sales Market Share by Countries
Table North America Alzheimer's Disease Patients Revenue by Countries (2014-2019) (Million US$)
Table North America Alzheimer's Disease Patients Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Alzheimer's Disease Patients Revenue Market Share by Countries
Figure United States Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure United States Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Canada Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Table North America Alzheimer's Disease Patients Sales by Product (2014-2019) (K Units)
Table North America Alzheimer's Disease Patients Sales Market Share by Product (2014-2019)
Figure 2018 North America Alzheimer's Disease Patients Market Share by Product
Table North America Alzheimer's Disease Patients Sales by End User (2014-2019) (K Units)
Table North America Alzheimer's Disease Patients Sales Market Share by End User (2014-2019)
Figure 2018 North America Alzheimer's Disease Patients Market Share by End User
Figure Europe Alzheimer's Disease Patients Sales Growth Rate 2014-2019 (K Units)
Figure Europe Alzheimer's Disease Patients Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Alzheimer's Disease Patients Sales by Countries (2014-2019) (K Units)
Table Europe Alzheimer's Disease Patients Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Alzheimer's Disease Patients Sales Market Share by Countries
Table Europe Alzheimer's Disease Patients Revenue by Countries (2014-2019) (Million US$)
Table Europe Alzheimer's Disease Patients Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Alzheimer's Disease Patients Revenue Market Share by Countries
Figure Germany Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Germany Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure France Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure France Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure UK Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Italy Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Russia Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Alzheimer's Disease Patients Sales by Product (2014-2019) (K Units)
Table Europe Alzheimer's Disease Patients Sales Market Share by Product (2014-2019)
Figure 2018 Europe Alzheimer's Disease Patients Market Share by Product
Table Europe Alzheimer's Disease Patients Sales by End User (2014-2019) (K Units)
Table Europe Alzheimer's Disease Patients Sales Market Share by End User (2014-2019)
Figure 2018 Europe Alzheimer's Disease Patients Market Share by End User
Figure Asia Pacific Alzheimer's Disease Patients Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Alzheimer's Disease Patients Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Alzheimer's Disease Patients Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Alzheimer's Disease Patients Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Alzheimer's Disease Patients Sales Market Share by Countries
Table Asia Pacific Alzheimer's Disease Patients Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Alzheimer's Disease Patients Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Alzheimer's Disease Patients Revenue Market Share by Countries
Figure China Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure China Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Japan Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Korea Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure India Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure India Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Australia Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Alzheimer's Disease Patients Sales by Product (2014-2019) (K Units)
Table Asia Pacific Alzheimer's Disease Patients Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Alzheimer's Disease Patients Market Share by Product
Table Asia Pacific Alzheimer's Disease Patients Sales by End User (2014-2019) (K Units)
Table Asia Pacific Alzheimer's Disease Patients Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Alzheimer's Disease Patients Market Share by End User
Figure Central & South America Alzheimer's Disease Patients Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Alzheimer's Disease Patients Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Alzheimer's Disease Patients Sales by Countries (2014-2019) (K Units)
Table Central & South America Alzheimer's Disease Patients Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Alzheimer's Disease Patients Sales Market Share by Countries
Table Central & South America Alzheimer's Disease Patients Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Alzheimer's Disease Patients Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Alzheimer's Disease Patients Revenue Market Share by Countries
Figure Brazil Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Alzheimer's Disease Patients Sales by Product (2014-2019) (K Units)
Table Central & South America Alzheimer's Disease Patients Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Alzheimer's Disease Patients Market Share by Product
Table Central & South America Alzheimer's Disease Patients Sales by End User (2014-2019) (K Units)
Table Central & South America Alzheimer's Disease Patients Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Alzheimer's Disease Patients Market Share by End User
Figure Middle East and Africa Alzheimer's Disease Patients Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Alzheimer's Disease Patients Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Alzheimer's Disease Patients Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Alzheimer's Disease Patients Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Alzheimer's Disease Patients Sales Market Share by Countries
Table Middle East and Africa Alzheimer's Disease Patients Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Alzheimer's Disease Patients Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Alzheimer's Disease Patients Revenue Market Share by Countries
Figure GCC Countries Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Alzheimer's Disease Patients Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Alzheimer's Disease Patients Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Alzheimer's Disease Patients Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Alzheimer's Disease Patients Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Alzheimer's Disease Patients Market Share by Product
Table Middle East and Africa Alzheimer's Disease Patients Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Alzheimer's Disease Patients Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Alzheimer's Disease Patients Market Share by End User
Table Forest Laboratorie Company Details
Table Forest Laboratorie Alzheimer's Disease Patients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Forest Laboratorie Recent Development
Table Eisai Company Details
Table Eisai Alzheimer's Disease Patients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eisai Recent Development
Table H. Lundbeck A/S Company Details
Table H. Lundbeck A/S Alzheimer's Disease Patients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table H. Lundbeck A/S Recent Development
Table Novartis Company Details
Table Novartis Alzheimer's Disease Patients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Merz GmbH & Co. KGaA Company Details
Table Merz GmbH & Co. KGaA Alzheimer's Disease Patients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merz GmbH & Co. KGaA Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Alzheimer's Disease Patients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table UCB Company Details
Table UCB Alzheimer's Disease Patients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table UCB Recent Development
Table Global Alzheimer's Disease Patients Sales Forecast by Regions 2019-2025 (K Units)
Table Global Alzheimer's Disease Patients Sales Market Share Forecast by Regions 2019-2025
Table Global Alzheimer's Disease Patients Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Alzheimer's Disease Patients Revenue Market Share Forecast by Regions 2019-2025
Table Global Alzheimer's Disease Patients Sales Forecast by Product 2019-2025 (K Units)
Table Global Alzheimer's Disease Patients Sales Market Share Forecast by Product 2019-2025
Table Global Alzheimer's Disease Patients Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Alzheimer's Disease Patients Revenue Market Share Forecast by Product 2019-2025
Table Global Alzheimer's Disease Patients Sales Forecast by End User 2019-2025 (K Units)
Table Global Alzheimer's Disease Patients Sales Market Share Forecast by End User 2019-2025
Figure North America Alzheimer's Disease Patients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Alzheimer's Disease Patients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Alzheimer's Disease Patients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Alzheimer's Disease Patients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Alzheimer's Disease Patients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Alzheimer's Disease Patients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Alzheimer's Disease Patients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Alzheimer's Disease Patients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Alzheimer's Disease Patients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Alzheimer's Disease Patients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Alzheimer's Disease Patients Value Chain
Table Alzheimer's Disease Patients Customers List
Table Alzheimer's Disease Patients Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
アルツハイマー病薬剤の世界市場：インサイト・予測 Global Alzheimer’s Drugs market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alzheimer’s Drugs. …- パーキンソン病薬の世界市場：インサイト・予測 Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease.The global Parkinsons disease Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end…
- セリアック病の世界市場：インサイト・予測 Celiac disease is a serious autoimmune disorder that can occur in genetically predisposed people where the ingestion of gluten leads to damage in the small intestine. It is estimated to affect 1 in 100 people worldwide.The global Celiac Disease market is valued at 130 million US$ in 2018 and will re…
- 脳疾患の世界市場：市場規模・現状・予測 Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of…
- 髄膜炎菌性疾患治療の世界市場：インサイト・予測 Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …